Skin Tags: What Labs to Get and Clinical Next Steps
Skin tags (acrochordons) can signal insulin resistance, prediabetes, or metabolic syndrome. Learn which labs to request, what results mean, and when to see a specialist.
Skin tags (acrochordons) can signal insulin resistance, prediabetes, or metabolic syndrome. Learn which labs to request, what results mean, and when to see a specialist.
A clinical breakdown of the causes behind sleep apnea symptoms, from obstructive airway collapse to central neurological signaling failures, with diagnosis paths and evidence-based treatments.
A guide to medications that worsen or improve sleep apnea symptoms, including GLP-1 agonists, solriamfetol, opioids, and benzodiazepines, with trial data and dosing details.
A clinical guide to bradycardia evaluation, including which labs to order, how slow heartbeat is diagnosed, common causes, and when treatment like a pacemaker is needed.
Learn the causes of slow wound healing, how it is diagnosed, and when delayed wound repair signals a condition that needs medical attention.
A differential guide to slowed thinking (bradyphrenia), covering thyroid dysfunction, depression, sleep disorders, medications, neurodegenerative disease, and metabolic causes with diagnosis and treatment pathways.
A guide to medications that can cause cognitive slowing and drugs used to treat bradyphrenia, with dosing details, trial data, and when to seek help.
A clinical guide to the causes of snoring, from nasal obstruction and obesity to obstructive sleep apnea. Includes diagnostic workup, treatments, and when snoring signals a serious condition.
Learn the causes of social withdrawal, how it is diagnosed, and when pulling away from others signals something that needs medical attention.
Learn how the Somogyi effect causes rebound morning hyperglycemia, which labs confirm it, and what clinical next steps your provider will recommend.
Why your stretch marks are fading, from natural collagen remodeling and hormonal shifts to topical retinoids and procedural treatments. Evidence-based causes prepared by the HealthRX.com Editorial Team.
Which medications cause stretch marks and which help them fade? A guide to tretinoin, corticosteroids, hyaluronic acid, and other drugs linked to striae formation and treatment.
Stretch marks naturally fade from red or purple to white over time. Learn when fading stretch marks are normal, when they signal an underlying condition, and what treatments dermatologists recommend.
Understand what causes subclinical hypothyroidism symptoms, how the condition is diagnosed, when treatment is warranted, and which underlying factors drive elevated TSH with normal free T4.
What an elevated TSH with normal free T4 means, which labs confirm subclinical hypothyroidism, when treatment is generally recommended, and what monitoring looks like if it is not.
Persistent sugar cravings can signal blood sugar dysregulation, nutrient deficiencies, or hormonal imbalance. Learn which labs to request, what causes sugar cravings, and evidence-based next steps.
Steroids, olanzapine, clozapine and mirtazapine can trigger sugar cravings; semaglutide, naltrexone and topiramate may reduce them, per clinical data.
A clinical guide to sulfur burps covering causes, diagnostic labs, breath tests, H. pylori screening, SIBO evaluation, and evidence-based treatment options.
A clinical breakdown of the causes behind excessive sweating, from primary hyperhidrosis to thyroid disease, medications, and infections, with diagnostic criteria and treatment options.
A guide to drug-induced hyperhidrosis and FDA-approved treatments for excessive sweating, including anticholinergics, oxybutynin, glycopyrrolate, and botulinum toxin.
Learn when excessive sweating (hyperhidrosis) signals a medical problem, what causes it, how doctors diagnose it, and which treatments actually work.
A clinical guide to hypohidrosis and anhidrosis, including which medications reduce sweating, underlying causes, diagnostic workup, and evidence-based treatment options.
A guide to medications linked to tendinitis and the drugs used to treat it, including fluoroquinolones, statins, NSAIDs, and corticosteroid injections.
A clinical guide to the causes, diagnosis, and treatment of tension-type headache, including when symptoms point to something more serious.
Learn which lab tests and evaluations matter for tension headaches, when imaging is needed, red-flag symptoms that change the workup, and evidence-based treatments.
Spironolactone can suppress the HPG axis and shrink testes; volume often recovers within 6-12 months after stopping. See thresholds and comparisons to other drugs.
A clinical guide to medications linked to throat fullness (globus sensation), including PPIs, SSRIs, GLP-1 agonists, ACE inhibitors, and evidence-based treatments.
A clinical guide to the medications linked to thyrotoxicosis and the drugs used to treat it, including antithyroid agents, beta-blockers, and iodine-based therapies.
A guide to the lab work, imaging, and specialist referrals you need after tinnitus onset, plus evidence-based treatment options.
No drug is FDA-approved for tinnitus, but off-label options like tricyclics, gabapentin, and CBT can ease symptoms. See which drugs worsen it too.
A clinical guide to medications that cause sleep-onset insomnia and prescription treatments that reduce time to fall asleep, with doses, trial data, and tapering advice.
Drug-induced fever causes 3-5% of unexplained fever cases. See culprit drug classes like antibiotics and allopurinol, plus antipyretics used to treat it.
Fever at or above 101°F for more than a few days, plus night sweats or weight loss, means it's time to see a doctor. Learn the red flags and causes.
A clinical guide to the differential diagnosis of unintended weight changes, covering thyroid disorders, diabetes, malignancy, medication effects, and when to seek evaluation.
Urinary urgency usually signals overactive bladder, UTI, or enlarged prostate. See how urinalysis and post-void residual testing pinpoint the cause.
A clinical guide to the most common and serious causes of vomiting, how physicians diagnose the underlying trigger, and when to seek emergency care.
A clinical guide to the laboratory workup, diagnostic evaluation, and evidence-based next steps for persistent or unexplained vomiting in adults.
Opioids, chemo agents, SSRIs and antibiotics can trigger vomiting. See which drugs cause it and which antiemetics, like ondansetron, treat it.
Learn what causes vomiting, how it is diagnosed, effective treatments, and the specific warning signs that mean you should see a doctor right away.
A weak urinary stream can signal BPH, urethral stricture, or neurogenic bladder. Learn the red flags, diagnostic workup, and treatment options that warrant medical evaluation.
A clinical guide to medications linked to weight gain and FDA-approved pharmacotherapies for weight management, including GLP-1 receptor agonists, antipsychotics, corticosteroids, and more.
Losing 5% or more of body weight unintentionally in 6-12 months warrants evaluation. See thresholds, causes and the tests doctors run first.
Board-reviewed guide to leukonychia (white spots on nails) covering the 8 most common causes, how doctors diagnose them, when they signal systemic disease, and what treatments actually work.
White spots on nails (leukonychia) are usually harmless, but certain patterns signal systemic disease. Learn what causes them, when to worry, and how they are diagnosed and treated.
Yellow eyes (scleral icterus) signal elevated bilirubin. Learn which blood tests, imaging studies, and specialist referrals you need, plus when yellowing demands emergency care.
Yellow skin without eye yellowing often means carotenoid pseudojaundice, not liver disease. True jaundice needs bilirubin above 2.5 mg/dL and affects the eyes first.
Tadalafil is not FDA-approved for erectile dysfunction or BPH in patients aged 12-17. This article reviews the limited evidence, off-label considerations, and the one pediatric indication where tadalafil data does exist.
Evidence-based review of tadalafil (generic) safety considerations for adolescents aged 12-17, including off-label use, pharmacokinetics, monitoring protocols, and clinical guidance.
Evidence-based guide to tadalafil dosing in older adults (65+), covering starting doses, renal adjustments, drug interactions, fall risk, and BPH considerations.
A guide to tadalafil's off-label applications beyond ED and BPH, graded by clinical evidence from RCTs, meta-analyses, and guideline endorsements.
How to dose generic tadalafil for adults aged 50 to 64, including daily vs. on-demand protocols, drug interactions, cardiovascular screening, and BPH overlap.
A clinical deep-dive into tadalafil's patent expiration, Paragraph IV challenges, and the generic timeline from 2017 onward, with FDA and trial-cited evidence.
An evidence-based review of tadalafil (generic) safety in pediatric patients under 12, covering FDA labeling, the STARTS trials, off-label risks, weight-based dosing considerations, and monitoring protocols.
How CYP3A4, CYP3A5, and PDE5A polymorphisms influence tadalafil metabolism, efficacy, and side-effect risk. Evidence-based guidance for clinicians considering pharmacogenomic testing.
Is tadalafil safe during pregnancy or breastfeeding? Review FDA labeling, animal reproductive data, human evidence, and clinical guidance for tadalafil in reproductive contexts.
A clinical review of real-world evidence for generic tadalafil 2.5-20 mg across erectile dysfunction and BPH, including registry studies, claims analyses, and post-market safety data.
Evidence-based guide to tadalafil dose adjustments in kidney disease, covering mild, moderate, and severe renal impairment plus dialysis patients, with FDA label data and primary-source citations.
FDA labeling lists organic nitrates as an absolute contraindication with tadalafil; nitrates must be deferred at least 48 hours after a tadalafil dose.
UnitedHealthcare typically covers generic tadalafil on Tier 3 with prior authorization. Learn formulary placement, PA criteria, step therapy rules, appeal steps, and cost-saving strategies.
A clinical review of tadalafil generic safety in men aged 18 to 29, covering dosing, side effects, cardiovascular risk, fertility, and long-term use considerations.